UBS’s CAREFUSION CORPORATION CFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$45K Buy
1,000
+100
+11% +$4.5K ﹤0.01% 6982
2014
Q2
$40K Sell
900
-1,000
-53% -$41.4K ﹤0.01% 7195
2014
Q1
$76K Sell
1,900
-16,800
-90% -$680K ﹤0.01% 6338
2013
Q4
$745K Buy
18,700
+11,300
+153% +$439K ﹤0.01% 3877
2013
Q3
$273K Buy
7,400
+5,300
+252% +$198K ﹤0.01% 4811
2013
Q2
$77K Buy
+2,100
New +$74.2K ﹤0.01% 6221

Other funds holding CFN

UBS's CFN Position: Q3 2014 in Review

UBS increased its CAREFUSION CORPORATION (CFN) stake by 14% in Q3 2014, buying an estimated $1.51M and bringing the position to 271,684 shares worth $12.3M. The position accounts for 0.01% of the portfolio, ranked #1290.

UBS first reported a position in CFN in Q2 2013 and has held it in 6 quarters since. 417 funds tracked by Wall St. Rank hold CFN as of Q3 2014.

  • UBS held 271,684 shares of CAREFUSION CORPORATION worth $12.3M as of Q3 2014.
  • UBS bought 33,629 CAREFUSION CORPORATION shares in Q3 2014, an estimated $1.51M.
  • CAREFUSION CORPORATION made up 0.01% of UBS's portfolio in Q3 2014, its #1290 holding.
  • UBS first reported a position in CAREFUSION CORPORATION in Q2 2013 and has held it in 6 quarters since.
  • 417 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.